We found that higher expression of the IL1B signature is associated with lower survival rate in multiple cancer types, especially in Low Grade Glioma (LGG) and in Kidney renal cell carcinoma (KIRC) (Supplementary Fig. 10). Here, IL1B is linked to central nervous system cancer.